Medicare Enrolled

Dr. Bruno Romeo, MD

Pulmonary Disease · Clearfield, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
820 TURNPIKE AVE, Clearfield, PA 16830
8147656644
Registered in NPPES since 2006
NPI: 1689615247 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Romeo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Romeo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Romeo

Dr. Bruno Romeo is a pulmonary disease specialist in Clearfield, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Romeo performed 939 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Romeo received a total of $12,484 from 43 pharmaceutical and/or device companies across 591 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Romeo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 34% volume in PA $12,484 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
939
Medicare services
Top 34% in PA for pulmonary disease
Not available
Unique patients (not deduplicated)
$42
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
494 $46 $68
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
104 $8 $40
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
82 $63 $101
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
76 $62 $120
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
73 $7 $37
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
71 $9 $37
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
22 $136 $491
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
17 $90 $136
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,484
Total received (2018-2024)
Avg $1,783/year across 7 years
Top 14% in PA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
591
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,938
2023
$2,363
2022
$1,987
2021
$1,134
2020
$1,194
2019
$1,695
2018
$2,173

Payments by company (2024)

AstraZeneca Pharmaceuticals LP
$461
GlaxoSmithKline, LLC.
$389
Actelion Pharmaceuticals US, Inc.
$294
Boehringer Ingelheim Pharmaceuticals, Inc.
$152
Takeda Pharmaceuticals U.S.A., Inc.
$136
HARMONY BIOSCIENCES LLC
$115
Regeneron Healthcare Solutions, Inc.
$93
GENZYME CORPORATION
$62
Amgen Inc.
$36
Vifor Pharma, Inc.
$31
Resmed Corp
$28
Merck Sharp & Dohme LLC
$25
Insmed, Inc.
$22
Mylan Specialty L.P.
$22
PFIZER INC.
$22
Inspire Medical Systems, Inc.
$20
Philips North America LLC
$17
E.R. Squibb & Sons, L.L.C.
$13
Top 3 companies account for 59.0% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$3,412
AstraZeneca Pharmaceuticals LP
$1,856
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,295
Janssen Pharmaceuticals, Inc
$773
Actelion Pharmaceuticals US, Inc.
$678
Amgen Inc.
$576
Takeda Pharmaceuticals U.S.A., Inc.
$466
PFIZER INC.
$390
Novartis Pharmaceuticals Corporation
$382
GENZYME CORPORATION
$378
Regeneron Healthcare Solutions, Inc.
$301
Novo Nordisk Inc
$236
Philips Electronics North America Corporation
$226
E.R. Squibb & Sons, L.L.C.
$205
Harmony Biosciences LLC
$172
HARMONY BIOSCIENCES LLC
$115
Grifols USA, LLC
$102
Amarin Pharma Inc.
$99
Mylan Specialty L.P.
$79
Allergan Inc.
$64
BioFire Diagnostics, LLC
$60
Baxter Healthcare
$55
United Therapeutics Corporation
$55
Merck Sharp & Dohme Corporation
$46
Astellas Pharma US Inc
$46
Merck Sharp & Dohme LLC
$43
SANOFI-AVENTIS U.S. LLC
$41
Vifor Pharma, Inc.
$31
Paratek Pharmaceuticals, Inc.
$28
Resmed Corp
$28
Mallinckrodt LLC
$27
Janssen Biotech, Inc.
$26
Sunovion Pharmaceuticals Inc.
$25
Allergan, Inc.
$23
Electromed, Inc.
$22
Insmed, Inc.
$22
Inspire Medical Systems, Inc.
$20
Philips North America LLC
$17
JAZZ PHARMACEUTICALS INC.
$14
SANOFI PASTEUR INC.
$13
Lilly USA, LLC
$12
Vanda Pharmaceuticals Inc.
$12
Advanced Respiratory, Inc
$11
Top 3 companies account for 52.6% of all-time payments
Associated products mentioned in payments ›
(8874) InCourage · (8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSENSE · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Aimovig · Arikayce · BASAGLAR · BEXSERO · BREO · BREZTRI · BioFire FilmArray · CAMZYOS · CHANTIX · COLOGUARD · DIFICID · DUPIXENT · ELIQUIS · ENTRESTO · EVENITY · FARXIGA · FASENRA · FLUBLOK QUADRIVALENT · Fanapt · GARDASIL 9 · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INSPIRE · INVOKANA · JARDIANCE · LINZESS · LONHALA MAGNAIR · LYRICA · NUCALA · NUZYRA · OFEV · OPSUMIT · Ozempic · PAXLOVID · PNEUMOVAX 23 · PREVNAR - 13 · Prolastin-C Liquid · Prolia · Repatha · Respiratoriy Care Undiv · SHINGRIX · SMARTVEST · SOLIQUA 100/33 · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TEZSPIRE · TOUJEO · TRELEGY ELLIPTA · TYVASO · The Vest System Model 105 Home Care · Tresiba · UBRELVY · UPTRAVI · VRAYLAR · Vascepa · WAKIX · Wakix · XARELTO · YUPELRI · Yupelri · Zemaira
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pulmonary disease specialist in Clearfield?
Compare pulmonary diseases in the Clearfield area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases in nearby ZIP areas
3
County median income
$60,181
Nearest hospital to ZIP centroid (approximate)
PENN HIGHLANDS DUBOIS
15.3 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Romeo is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Romeo experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Romeo performed 494 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Romeo receive payments from pharmaceutical companies?
Yes. Dr. Romeo received a total of $12,484 from 43 companies across 591 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Romeo's costs compare to other pulmonary diseases in Clearfield?
Dr. Romeo's average Medicare payment per service is $42. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Romeo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →